Repligen
RGEN
#2042
Rank
A$14.07 B
Marketcap
A$250.05
Share price
-0.46%
Change (1 day)
7.89%
Change (1 year)
Categories

Repligen (RGEN) - Net assets

Net assets on the balance sheet as of September 2025 : A$3.14 Billion

According to Repligen 's latest financial reports the company has A$3.14 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Repligen - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$A$3.17 B9.97%
2023-12-31$A$2.88 B2.71%
2022-12-31$A$2.80 B16.31%
2021-12-31$A$2.41 B21.38%
2020-12-31$A$1.98 B31.38%
2019-12-31$A$1.51 B73.23%
2018-12-31$A$0.87 B15.32%
2017-12-31$A$0.75 B223.63%
2016-12-31$A$0.23 B38.95%
2015-12-31$A$0.16 B23.42%
2014-12-31$A$0.13 B17.22%
2013-12-31$A$0.11 B43.87%
2012-12-31$A$80.95 M
2011-03-31$A$64.91 M-9.61%
2010-03-31$A$71.81 M-27.37%
2009-03-31$A$98.88 M42.08%
2008-03-31$A$69.6 M120.2%
2007-03-31$A$31.6 M-12.28%
2006-03-31$A$36.03 M14.64%
2005-03-31$A$31.43 M-12.81%
2004-03-31$A$36.05 M-11.41%
2003-03-31$A$40.69 M-17.89%
2002-03-31$A$49.56 M-22.46%
2001-03-31$A$63.91 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novavax
NVAX
-A$0.24 Billion-107.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
A$9.13 B 190.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
A$4.53 B 44.19%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
A$28.69 B 813.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
A$77.16 B 2,355.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$28.05 B 792.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$140.43 B 4,369.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
A$2.96 B-5.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
A$9.41 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
A$5.20 B 65.66%๐Ÿ‡บ๐Ÿ‡ธ USA